日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The blood transcriptional response in patients developing intensive care unit-acquired pneumonia

重症监护病房获得性肺炎患者的血液转录反应

de Brabander, Justin; Michels, Erik H A; Butler, Joe M; Reijnders, Tom D Y; van Engelen, Tjitske S R; Leite, Giuseppe G F; Paling, Fleur P; Klarenbeek, Augustijn M; Sie, Daoud L S; Boyer, Roxane E; Sweeney, Timothy E; Bonten, Marc J M; Timbermont, Leen; Malhotra-Kumar, Surbhi; Kluytmans, Jan A J W; Peters-Sengers, Hessel; van der Poll, Tom

Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis

关于继发性进展型多发性硬化症患者中西尼莫德相关淋巴细胞减少症的真实世界数据

Gilmartin, Christopher Gs; Hoyle, Natasha; Garjani, Afagh; Dixon, Terri; Jos, Helena; Paling, David; Brownlee, Wallace; Tench, Christopher; Evangelou, Nikos

Summary of Research: Cost‑Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis

研究概要:法瑞西单抗治疗糖尿病性黄斑水肿(DMO)的成本效益分析:一项英国研究

Bührer, Christian; Paling, Thomas; Gale, Richard; Paulo, Tatiana; Bagijn, Marloes

Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials

乌布妥昔单抗与其他单克隆抗体治疗复发型多发性硬化症的疗效和耐受性比较:一项随机试验的系统评价和网络荟萃分析

Moloney, Eoin; Mashayekhi, Atefeh; Sharma, Sakshi; Kontogiannis, Vasileios; Ansaripour, Amir; Brownlee, Wallace; Paling, David; Javanbakht, Mehdi

Brain reserve and physical disability in secondary progressive multiple sclerosis

继发性进展型多发性硬化症的脑储备和身体残疾

John, Nevin; Li, Yingtong; De Angelis, Floriana; Stutters, Jonathan; Prados Carrasco, Ferran; Eshaghi, Arman; Doshi, Anisha; Calvi, Alberto; Williams, Thomas; Plantone, Domenico; Phan, Thanh; Barkhof, Frederik; Chataway, Jeremy; Ourselin, Sebastien; Braisher, Marie; Beyene, Tiggy; Bassan, Vanessa; Zapata, Alvin; Chandran, Siddharthan; Connick, Peter; Lyle, Dawn; Cameron, James; Mollison, Daisy; Colville, Shuna; Dhillon, Baljean; Ross, Moira; Cranswick, Gina; Walker, Allan; Smith, Lorraine; Giovannoni, Gavin; Gnanapavan, Sharmilee; Nicholas, Richard; Rashid, Waqar; Aram, Julia; Ford, Helen; Pavitt, Sue H; Overell, James; Young, Carolyn; Arndt, Heinke; Duddy, Martin; Guadagno, Joe; Evangelou, Nikolaos; Craner, Matthew; Palace, Jacqueline; Hobart, Jeremy; Sharrack, Basil; Paling, David; Hawkins, Clive; Kalra, Seema; McLean, Brendan; Stallard, Nigel; Bastow, Roger

Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial

自体造血干细胞移植与阿仑单抗、奥瑞珠单抗、奥法妥木单抗或克拉屈滨治疗复发缓解型多发性硬化症的疗效和安全性比较(StarMS):一项随机对照试验方案

Brittain, Gavin; Petrie, Jennifer; Duffy, Kate E M; Glover, Rachel; Hullock, Katie; Papaioannou, Diana; Roldan, Elisa; Beecher, Colette; Bursnall, Matthew; Ciccarelli, Olga; Coles, Alasdair J; Cooper, Cindy; Giovannoni, Gavin; Gabriel, Ian; Kazmi, Majid; Kyriakou, Charalampia; Nicholas, Richard; Paling, David; Peniket, Andy; Scolding, Neil; Silber, Eli; de Silva, Thushan; Venneri, Annalena; Walters, Stephen J; Young, Carolyn; Muraro, Paolo A; Sharrack, Basil; Snowden, John A

Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis

法瑞西单抗治疗糖尿病性黄斑水肿(DMO)的成本效益分析:一项英国研究

Bührer, Christian; Paling, Thomas; Gale, Richard; Paulo, Tatiana; Bagijn, Marloes

Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization

术前有无金黄色葡萄球菌定植的患者术后金黄色葡萄球菌感染情况

Troeman, Darren P R; Hazard, Derek; Timbermont, Leen; Malhotra-Kumar, Surbhi; van Werkhoven, Cornelis H; Wolkewitz, Martin; Ruzin, Alexey; Goossens, Herman; Bonten, Marc J M; Harbarth, Stephan; Sifakis, Frangiscos; Kluytmans, Jan A J W; Vlaeminck, Jelle; Vilken, Tuba; Xavier, Basil Britto; Lammens, Christine; van Esschoten, Marjolein; Paling, Fleur P; Recanatini, Claudia; Coenjaerts, Frank; Sellman, Bret; Tkaczyk, Christine; Weber, Susanne; Ekkelenkamp, Miquel Bart; van der Laan, Lijckle; Vierhout, Bastiaan P; Couvé-Deacon, Elodie; David, Miruna; Chadwick, David; Llewelyn, Martin J; Ustianowski, Andrew; Bateman, Antony; Mawer, Damian; Carevic, Biljana; Konstantinovic, Sonja; Djordjevic, Zorana; Del Toro-López, María Dolores; Gallego, Juan Pablo Horcajada; Escudero, Dolores; Rojo, Miquel Pujol; Torre-Cisneros, Julian; Castelli, Francesco; Nardi, Giuseppe; Barbadoro, Pamela; Altmets, Mait; Mitt, Piret; Todor, Adrian; Bubenek-Turconi, Serban-Ion; Corneci, Dan; Sandesc, Dorel; Gheorghita, Valeriu; Brat, Radim; Hanke, Ivo; Neumann, Jan; Tomáš, Tomáš; Laffut, Wim; Van den Abeele, Anne-Marie

The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment

奥法妥木单抗(一种全人源抗CD20单克隆抗体)的研发及其在复发型多发性硬化症治疗中的实际应用

Hauser, Stephen L; Kappos, Ludwig; Bar-Or, Amit; Wiendl, Heinz; Paling, David; Williams, Mitzi; Gold, Ralf; Chan, Andrew; Milo, Ron; Das Gupta, Ayan; Karlsson, Goeril; Sullivan, Roseanne; Graham, Gordon; Merschhemke, Martin; Häring, Dieter A; Vermersch, Patrick

Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis

复发型多发性硬化症患者长期皮下注射奥法妥木单抗的耐受性

Kramer, John; Linker, Ralf; Paling, David; Czaplinski, Adam; Hoffmann, Olaf; Yong, V Wee; Barker, Noreen; Ross, Amy Perrin; Lucassen, Elisabeth; Gufran, Mohammad; Hu, Xixi; Zielman, Ronald; Seifer, Gustavo; Vermersch, Patrick